News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
589,135 Results
Type
Article (20918)
Company Profile (345)
Press Release (567866)
Multimedia
Podcasts (129)
Webinars (16)
Section
Business (194409)
Career Advice (436)
Deals (29909)
Drug Delivery (73)
Drug Development (71365)
Employer Resources (40)
FDA (12280)
Job Trends (10571)
News (285221)
Policy (22151)
Tag
2025 Best Places to Work (16)
2026 Best Places to Work (25)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (10)
2027 Biotech Beach Standard (5)
2027 Genetown Digital (3)
2027 Genetown Elite (1)
2027 Genetown Standard (5)
2027 NextGen (8)
2027 Pharm Country Digital (1)
2027 Pharm Country Standard (3)
40 Under 40 (4)
Academia (1257)
Accelerated approval (51)
ADA (39)
Adcomms (16)
Allergies (160)
Alliances (41155)
ALS (244)
Alzheimer's disease (1561)
Antibody-drug conjugate (ADC) (667)
Approvals (13009)
Artificial intelligence (691)
ASCO (274)
Autoimmune disease (453)
Automation (44)
Bankruptcy (304)
Belgium (30)
Best Places to Work (8501)
BIO (67)
Biologics (85)
BIOSECURE Act (6)
Biosimilars (203)
BioSpace Insights (92)
Biotechnology (228)
Bispecific (56)
Bladder cancer (195)
Brain cancer (76)
Breast cancer (754)
Cancer (6365)
Cardiovascular disease (461)
Career advice (384)
Career pathing (16)
CAR-T (377)
CDC (11)
CDMO (138)
Celiac Disease (4)
Cell therapy (1006)
Cervical cancer (48)
Clinical research (64635)
Collaboration (2271)
Commercialization (60)
Company closure (4)
Compensation (1771)
Complete response letters (80)
COVID-19 (1469)
CRISPR (140)
CRO (3)
C-suite (1352)
Cystic fibrosis (151)
Data (9475)
Denatured (30)
Depression (173)
Dermatology (165)
Diabetes (562)
Diagnostics (4962)
Digital health (50)
Diversity (6)
Diversity, equity & inclusion (12)
Drug discovery (401)
Drug pricing (60)
Drug shortages (6)
Duchenne muscular dystrophy (356)
Earnings (81633)
Editorial (38)
Employer branding (6)
Employer resources (38)
ESMO (383)
Events (105356)
Executive appointments (1062)
Eye disease (17)
FDA (16297)
Fibrodysplasia Ossificans Progressiva (15)
Fragile X (6)
Friedreich's ataxia (29)
Frontotemporal dementia (38)
Funding (1845)
Gene editing (285)
Generative AI (53)
Gene therapy (802)
GLP-1 (750)
Government (1779)
Grass and pollen (4)
Guidances (343)
Healthcare (12154)
Hematology (178)
HIV (81)
Huntington's disease (77)
Idiopathic pulmonary fibrosis (11)
IgA nephropathy (130)
Immunology and inflammation (312)
Immuno-oncology (134)
Indications (255)
Infectious disease (1757)
Inflammatory bowel disease (234)
Inflation Reduction Act (12)
Influenza (101)
Intellectual property (340)
Interviews (58)
IPO (14391)
IRA (13)
Job creations (2423)
Job search strategy (340)
JPM (41)
Kidney cancer (23)
Kidney disease (147)
Labor market (44)
Layoffs (318)
Leadership (22)
Legal (5649)
Licensing (108)
Liver cancer (72)
Longevity (46)
Lung cancer (903)
Lung diease (19)
Lymphoma (448)
Machine learning (50)
Management (10)
Manufacturing (997)
Marketing (33)
MASH (208)
Medical affairs (4)
Medical device (9993)
Medtech (10219)
Mergers & acquisitions (16848)
Metabolic disorders (1394)
Middle East (1)
mRNA (240)
Multiple sclerosis (186)
Multispecific (6)
NASH (14)
Netherlands (19)
Neurodegenerative disease (499)
Neuropsychiatric disorders (114)
Neuroscience (3306)
Neurotech (3)
NextGen: Class of 2026 (4128)
Non-profit (1522)
Now hiring (49)
Obesity (584)
Opinion (166)
Ovarian cancer (260)
Pain (265)
Pancreatic cancer (378)
Parkinson's disease (409)
Partnered (26)
Patents (667)
Patient advocacy (7)
Patient recruitment (845)
Patient selection (95)
Peanut (61)
People (50083)
Peptides (35)
Pharmaceutical (51)
Pharmacy benefit managers (16)
Phase 1 (21340)
Phase 2 (29188)
Phase 3 (19856)
Pipeline (12124)
Policy (123)
Postmarket research (1891)
Preclinical (9108)
Press Release (52)
Prostate cancer (329)
Psychedelics (90)
Radioligand (3)
Radiopharmaceuticals (386)
Rare diseases (1255)
Real estate (3781)
Recruiting (14)
Regenerative medicine (28)
Regulatory (20105)
Reports (43)
Research institute (1345)
Resumes & cover letters (59)
Rett syndrome (57)
RNA editing (38)
RSV (61)
Schizophrenia (194)
Series A (347)
Series B (238)
Service/supplier (5)
Sickle cell disease (131)
Special edition (24)
Spinal muscular atrophy (149)
Sponsored (25)
Startups (3135)
State (1)
Stem cells (7)
Stomach cancer (10)
Substance use disorders (22)
Supply chain (82)
Switzerland (15)
Tariffs (21)
The Weekly (97)
Vaccines (628)
Venture capital (124)
Weight loss (298)
Wet AMD (5)
Women's health (131)
Worklife (4)
Date
Today (154)
Last 7 days (752)
Last 30 days (3142)
Last 365 days (26288)
2026 (23701)
2025 (25758)
2024 (30028)
2023 (33976)
2022 (43313)
2021 (45731)
2020 (40883)
2019 (29829)
2018 (22460)
2017 (24178)
2016 (22652)
2015 (28865)
2014 (24869)
2013 (20673)
2012 (22487)
2011 (22746)
2010 (22422)
Location
Africa (343)
Alabama (101)
Alaska (3)
Arizona (377)
Arkansas (15)
Asia (29399)
Australia (4534)
California (15425)
Canada (4117)
China (1568)
Colorado (646)
Connecticut (606)
Delaware (416)
Europe (54767)
Florida (2249)
Georgia (464)
Hawaii (4)
Idaho (47)
Illinois (1065)
India (108)
Indiana (483)
Iowa (25)
Japan (634)
Kansas (121)
Kentucky (42)
Louisiana (46)
Maine (38)
Maryland (1599)
Massachusetts (11098)
Michigan (340)
Minnesota (702)
Mississippi (6)
Missouri (102)
Montana (32)
Nebraska (14)
Nevada (161)
New Hampshire (76)
New Jersey (3605)
New Mexico (19)
New York (3764)
North Carolina (1863)
North Dakota (11)
Northern California (8019)
Ohio (383)
Oklahoma (16)
Oregon (37)
Pennsylvania (2971)
Puerto Rico (28)
Rhode Island (43)
South America (528)
South Carolina (86)
South Dakota (1)
Southern California (6178)
Tennessee (161)
Texas (2506)
United States (51918)
Utah (452)
Vermont (1)
Virginia (276)
Washington D.C. (52)
Washington State (1222)
West Virginia (2)
Wisconsin (127)
Wyoming (2)
589,135 Results for "xortx therapeutics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
XORTX Completes Manufacturing of Clinical Drug Supply
November 16, 2026
·
9 min read
Press Releases
XORTX Patent Allowed for XRx-101 Program by Japan Patent Office
November 15, 2026
·
7 min read
Press Releases
XORTX Announces Director Resignation
August 2, 2026
·
3 min read
Press Releases
XORTX Appoints New Director
July 29, 2026
·
4 min read
Press Releases
XORTX Announces Termination and Postponement of Investor Relations Program
August 28, 2026
·
4 min read
Press Releases
XORTX Announces Initiation of Clinical and Commercial Manufacturing of XORLO™
September 10, 2026
·
7 min read
Press Releases
XORTX Outlines Anticipated Health Canada Clinical Trial Application for XRx-026 for Gout
October 8, 2026
·
9 min read
Press Releases
XORTX Announces Planned FDA IND Submission for XRx-026 Gout Program Using XORLO™, Targeting USD$700M+ U.S. Gout Market Opportunity
September 18, 2026
·
8 min read
Press Releases
XORTX Announces US$5 Million Public Offering
May 14, 2026
·
4 min read
Press Releases
XORTX Meets Nasdaq Continued Listing Requirements
April 21, 2026
·
3 min read
1 of 58,914
Next